EE9400183A - Vaccine and use of human immunodeficiency virus - Google Patents

Vaccine and use of human immunodeficiency virus

Info

Publication number
EE9400183A
EE9400183A EE9400183A EE9400183A EE9400183A EE 9400183 A EE9400183 A EE 9400183A EE 9400183 A EE9400183 A EE 9400183A EE 9400183 A EE9400183 A EE 9400183A EE 9400183 A EE9400183 A EE 9400183A
Authority
EE
Estonia
Prior art keywords
vaccine
immunodeficiency virus
human immunodeficiency
human
virus
Prior art date
Application number
EE9400183A
Other languages
Estonian (et)
Inventor
E. Smith Gale
Volvovitz Franklin
Original Assignee
Microgenesys, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microgenesys, Inc. filed Critical Microgenesys, Inc.
Publication of EE9400183A publication Critical patent/EE9400183A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EE9400183A 1991-06-11 1994-09-21 Vaccine and use of human immunodeficiency virus EE9400183A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71415291A 1991-06-11 1991-06-11

Publications (1)

Publication Number Publication Date
EE9400183A true EE9400183A (en) 1995-12-15

Family

ID=24868938

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400183A EE9400183A (en) 1991-06-11 1994-09-21 Vaccine and use of human immunodeficiency virus

Country Status (18)

Country Link
EP (1) EP0542998A1 (en)
JP (1) JPH06501851A (en)
CN (1) CN1068266A (en)
AU (2) AU2193192A (en)
BG (1) BG97519A (en)
CA (1) CA2087732A1 (en)
EE (1) EE9400183A (en)
FI (1) FI930577L (en)
HU (1) HUT68355A (en)
IE (1) IE921875A1 (en)
IL (1) IL102092A (en)
LT (1) LT3365B (en)
MX (1) MX9202781A (en)
PL (1) PL297849A1 (en)
PT (1) PT100584A (en)
SK (1) SK18993A3 (en)
WO (1) WO1992022654A1 (en)
ZA (1) ZA924150B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE40786E1 (en) * 1984-03-16 2009-06-23 The United States Of America As Represented By The Secretary Of The Army Vaccines against intracellular pathogens using antigens encapsulated within biodegradable-biocompatible microspheres
US6017536A (en) * 1993-06-07 2000-01-25 Trimeris, Inc. Simian immunodeficiency virus peptides with antifusogenic and antiviral activities
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US6479055B1 (en) 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
WO1995017515A1 (en) * 1993-12-23 1995-06-29 University Technologies International Inc. Methods of expressing proteins in insect cells and methods of killing insects
AU723537B2 (en) 1995-06-07 2000-08-31 Trimeris Inc. The treatment of HIV and other viral infections using combinatorial therapy
US6395541B1 (en) 1996-05-23 2002-05-28 The Rockefeller University Methods for the identification of compounds capable of inhibiting HIV-1 viral replication employing murine cell lines expressing human topoisomerase I
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US6077662A (en) * 1996-11-27 2000-06-20 Emory University Virus-like particles, methods and immunogenic compositions
US6214540B1 (en) 1997-03-26 2001-04-10 University Of Maryland Biotechnology Institute Chemokines that inhibit immunodeficiency virus infection and methods based thereon
US6583109B1 (en) 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
US6548631B1 (en) 1997-09-16 2003-04-15 BIOMéRIEUX, INC. Macrophage derived chemokine (MDC) as an anti-viral agent for the treatment and prevention of lentivirus infection
US6750008B1 (en) 1999-07-09 2004-06-15 Trimeris, Inc. Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
US7994278B1 (en) 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
US6623741B1 (en) 2000-02-29 2003-09-23 Trimeris, Inc. Methods and compositions for inhibition of membrane fusion-associated events including RSV transmission
AUPS065002A0 (en) 2002-02-20 2002-03-14 Immunaid Pty Ltd Strategy for retroviral immunotherapy
JP2006509039A (en) * 2002-12-03 2006-03-16 ユニバーシティ オブ マサチューセッツ Multivalent primary HIV-1 glycoprotein DNA vaccine and vaccination method
PL1692516T3 (en) 2003-10-24 2011-05-31 Immunaid Pty Ltd The method of therapy
GT200800303A (en) 2007-12-24 2009-09-18 ANTI-RETROVIRAL COMBINATION
PT2435825E (en) 2009-05-27 2015-11-02 Biotempus Ltd Methods of treating diseases
AU2012298125B2 (en) 2011-08-19 2015-09-24 Immortal Spirit Limited Antibody and antibody-containing composition
CN102961760B (en) * 2011-09-01 2017-07-18 常州文松生物技术有限公司 Overlapping peptide used as reagent for preparing skin test and detecting specific cellular immunity and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89118A0 (en) * 1988-02-03 1989-08-15 Microgenesys Inc Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1

Also Published As

Publication number Publication date
SK18993A3 (en) 1993-10-06
FI930577A7 (en) 1993-03-24
MX9202781A (en) 1993-04-01
HU9300686D0 (en) 1993-06-28
IL102092A0 (en) 1993-01-14
AU4028895A (en) 1996-02-22
HUT68355A (en) 1995-06-28
LTIP335A (en) 1995-01-31
AU2193192A (en) 1993-01-12
LT3365B (en) 1995-07-25
PL297849A1 (en) 1994-01-24
BG97519A (en) 1994-03-24
JPH06501851A (en) 1994-03-03
IL102092A (en) 1996-11-14
ZA924150B (en) 1993-02-24
PT100584A (en) 1993-07-30
FI930577A0 (en) 1993-02-10
IE921875A1 (en) 1992-12-16
CA2087732A1 (en) 1992-12-12
FI930577L (en) 1993-03-24
WO1992022654A1 (en) 1992-12-23
EP0542998A1 (en) 1993-05-26
CN1068266A (en) 1993-01-27

Similar Documents

Publication Publication Date Title
EE9400183A (en) Vaccine and use of human immunodeficiency virus
CY2007030I2 (en) HUMAN MATTIO VIRUS VACCINE (TYPE 18)
NO921012D0 (en) PHARMACEUTICAL PREPARATIONS AND THEIR USE
FI955248A7 (en) 1-Biphenylmethylimidazole derivatives, their preparation and therapeutic use
BR9206131A (en) Hepatitis C: diagnosis and vaccines
FI942138A7 (en) Preparation and use of multimeric hemoglobins
FI935072A7 (en) New perhydroisoindoles and their preparation
EE03025B1 (en) Organic salts of immunomodulatory N, N'-diacetylcystine, their preparation and use
FI931393A7 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
FI922983A7 (en) Pyrimidine-4-carboxamide derivatives, their preparation and therapeutic use
KR870700638A (en) Use of gonorrhea mainly as iron-regulated protein and its vaccine
FI914611A7 (en) 2-Aminopyrimidine-4-carboxamide derivatives, their preparation and therapeutic use
FI912784A7 (en) Preparation and use of porphyrins
FI941287A0 (en) Triazoloquinoxaline-1,4-diones and their preparation and use
FI925261A7 (en) Diagnosis and treatment of viral hepatitis
IL99851A0 (en) Muramyldipeptide derivatives and influenza vaccine containing them
FI934221A7 (en) Piperidine derivatives, their preparation and therapeutic use
FI920663A7 (en) Polyhydroxycyclopentane derivatives, their preparation and therapeutic use
FI921814A7 (en) 2-Aminopyrimidine-4-carboxamide derivatives, their preparation and therapeutic use
DE69032787D1 (en) MUTANT PSEUDORABIES VIRUS AND VACCINE CONTAINING THE SAME
FI971897L (en) Detection of human retrovirus infection
FI895286A7 (en) Phenyloxypropanolamines, their preparation and therapeutic use
IT1239064B (en) THERAPEUTIC USE OF DIPYRIDAMOL
FI922980A7 (en) 2-Piperidinylpyrimidine-4-carboxamide derivatives, their preparation and therapeutic use
IL102815A0 (en) Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus